Growth Metrics

Merck (MRK) Dividends payables (2016 - 2026)

Merck has reported Dividends payables over the past 18 years, most recently at $2.1 billion for Q1 2026.

  • Quarterly Dividends payables rose 3.18% to $2.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.1 billion through Mar 2026, up 3.18% year-over-year, with the annual reading at $2.1 billion for FY2025, 2.69% up from the prior year.
  • Dividends payables was $2.1 billion for Q1 2026 at Merck, roughly flat from $2.1 billion in the prior quarter.
  • Over five years, Dividends payables peaked at $2.1 billion in Q1 2026 and troughed at $1.8 billion in Q2 2022.
  • The 5-year median for Dividends payables is $2.0 billion (2024), against an average of $2.0 billion.
  • Year-over-year, Dividends payables increased 7.68% in 2023 and then increased 2.69% in 2025.
  • A 5-year view of Dividends payables shows it stood at $1.9 billion in 2022, then increased by 5.36% to $2.0 billion in 2023, then grew by 4.99% to $2.1 billion in 2024, then grew by 2.69% to $2.1 billion in 2025, then rose by 0.14% to $2.1 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Dividends payables are $2.1 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.0 billion (Q3 2025).